| P2093 | author name string | Anutosh Chakraborty | |
| P2860 | cites work | Multiple modes of cytoplasmic dynein regulation | Q83531140 |
| | An affinity reagent for the recognition of pyrophosphorylated peptides | Q86657216 |
| | Elucidating diphosphoinositol polyphosphate function with nonhydrolyzable analogues | Q88005751 |
| | Cloning and characterisation of hAps1 and hAps2, human diadenosine polyphosphate-metabolising Nudix hydrolases | Q21284394 |
| | Synthesis of diphosphoinositol pentakisphosphate by a newly identified family of higher inositol polyphosphate kinases | Q22010845 |
| | Site-directed mutagenesis of diphosphoinositol polyphosphate phosphohydrolase, a dual specificity NUDT enzyme that attacks diadenosine polyphosphates and diphosphoinositol polyphosphates | Q22010877 |
| | Discovery of molecular and catalytic diversity among human diphosphoinositol-polyphosphate phosphohydrolases. An expanding Nudt family | Q22253958 |
| | Inositol hexakisphosphate kinase 2 mediates growth suppressive and apoptotic effects of interferon-beta in ovarian carcinoma cells | Q24291206 |
| | Identification and characterization of a novel inositol hexakisphosphate kinase | Q24291558 |
| | A conserved family of enzymes that phosphorylate inositol hexakisphosphate | Q24301881 |
| | Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach | Q24321897 |
| | Purification, sequencing, and molecular identification of a mammalian PP-InsP5 kinase that is activated when cells are exposed to hyperosmotic stress | Q24337620 |
| | Biological variability in the structures of diphosphoinositol polyphosphates in Dictyostelium discoideum and mammalian cells | Q24530557 |
| | A novel context for the 'MutT' module, a guardian of cell integrity, in a diphosphoinositol polyphosphate phosphohydrolase | Q24533397 |
| | Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA | Q24568308 |
| | A quantitative atlas of mitotic phosphorylation | Q24646817 |
| | Effect of inositol hexakisphosphate kinase 2 on transforming growth factor beta-activated kinase 1 and NF-kappaB activation | Q24670467 |
| | Inositol hexakisphosphate kinase 2 sensitizes ovarian carcinoma cells to multiple cancer therapeutics | Q24672792 |
| | Inositol hexakisphosphate suppresses excitatory neurotransmission via synaptotagmin-1 C2B domain in the hippocampal neuron | Q26269873 |
| | The emerging roles of inositol pyrophosphates in eukaryotic cell physiology | Q26786441 |
| | Insulin receptor signaling in normal and insulin-resistant states | Q26823171 |
| | The enzymes of human diphosphoinositol polyphosphate metabolism | Q26851038 |
| | Signaling through C2 domains: more than one lipid target | Q27014032 |
| | Structural basis for an inositol pyrophosphate kinase surmounting phosphate crowding | Q27675827 |
| | IP6K structure and the molecular determinants of catalytic specificity in an inositol phosphate kinase family | Q27684442 |
| | The inositol hexakisphosphate kinase family. Catalytic flexibility and function in yeast vacuole biogenesis | Q27929981 |
| | Identification of an evolutionarily conserved family of inorganic polyphosphate endopolyphosphatases | Q27932475 |
| | Structural analysis and detection of biological inositol pyrophosphates reveal that the family of VIP/diphosphoinositol pentakisphosphate kinases are 1/3-kinases | Q27939197 |
| | Cloning and characterization of two human VIP1-like inositol hexakisphosphate and diphosphoinositol pentakisphosphate kinases | Q28116072 |
| | Back in the water: the return of the inositol phosphates | Q28186774 |
| | Genetic rationale for microheterogeneity of human diphosphoinositol polyphosphate phosphohydrolase type 2 | Q28190925 |
| | Evolution of protein kinase signaling from yeast to man | Q28205635 |
| | Nudix hydrolases that degrade dinucleoside and diphosphoinositol polyphosphates also have 5-phosphoribosyl 1-pyrophosphate (PRPP) pyrophosphatase activity that generates the glycolytic activator ribose 1,5-bisphosphate | Q28205958 |
| | Inorganic polyphosphate: essential for growth and survival | Q28240351 |
| | The IHPK1 gene is disrupted at the 3p21.31 breakpoint of t(3;9) in a family with type 2 diabetes mellitus | Q28268909 |
| | The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and Aging | Q28276378 |
| | Prediction of the coding sequences of unidentified human genes. VI. The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by analysis of cDNA clones from cell line KG-1 and brain | Q28304043 |
| | The blood-testis barrier and its implications for male contraception | Q28395237 |
| | Paralogous murine Nudt10 and Nudt11 genes have differential expression patterns but encode identical proteins that are physiologically competent diphosphoinositol polyphosphate phosphohydrolases | Q28510332 |
| | Human genome-wide RNAi screen identifies an essential role for inositol pyrophosphates in Type-I interferon response | Q28540195 |
| | GRAB: a physiologic guanine nucleotide exchange factor for Rab3A, which interacts with inositol hexakisphosphate kinase | Q28571302 |
| | Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains | Q28609779 |
| | Inositol pyrophosphates: why so many phosphates? | Q28652347 |
| | IP3 3-kinase opposes NGF driven neurite outgrowth | Q28731851 |
| | The versatility and universality of calcium signalling | Q29547402 |
| | Histone methylation in transcriptional control | Q29616553 |
| | Mechanisms of specificity in protein phosphorylation | Q29617541 |
| | Linking DNA methylation and histone modification: patterns and paradigms | Q29617801 |
| | Inositol hexakisphosphate kinase-2 acts as an effector of the vertebrate Hedgehog pathway | Q30497487 |
| | Intramolecular and intermolecular interactions of protein kinase B define its activation in vivo | Q33281051 |
| | How does synaptotagmin trigger neurotransmitter release? | Q33345212 |
| | Inhibition of the ER Ca2+ pump forces multidrug-resistant cells deficient in Bak and Bax into necrosis | Q33516101 |
| | Deletion of inositol hexakisphosphate kinase 1 (IP6K1) reduces cell migration and invasion, conferring protection from aerodigestive tract carcinoma in mice | Q37020337 |
| | Cellular energetic status supervises the synthesis of bis-diphosphoinositol tetrakisphosphate independently of AMP-activated protein kinase | Q37077554 |
| | Inositol pyrophosphates inhibit synaptotagmin-dependent exocytosis. | Q37126685 |
| | Arsenic-based antineoplastic drugs and their mechanisms of action | Q37145891 |
| | Inositol pyrophosphates and their unique metabolic complexity: analysis by gel electrophoresis | Q37186675 |
| | Inositol Hexakisphosphate Kinase 3 Regulates Metabolism and Lifespan in Mice | Q37219919 |
| | Identification of the serine 307 of LKB1 as a novel phosphorylation site essential for its nucleocytoplasmic transport and endothelial cell angiogenesis | Q37233462 |
| | Diphosphoinositol polyphosphates: metabolic messengers? | Q37268113 |
| | Inositol pyrophosphates regulate JMJD2C-dependent histone demethylation. | Q37340761 |
| | Inositol hexakisphosphate kinase 1 (IP6K1) activity is required for cytoplasmic dynein-driven transport | Q37394301 |
| | Inositol polyphosphates intersect with signaling and metabolic networks via two distinct mechanisms. | Q37398176 |
| | Understanding inositol pyrophosphate metabolism and function: kinetic characterization of the DIPPs | Q37416185 |
| | Inositol pyrophosphate mediated pyrophosphorylation of AP3B1 regulates HIV-1 Gag release | Q37482212 |
| | Inositol pyrophosphates: structure, enzymology and function | Q37588509 |
| | PPIP5K1 modulates ligand competition between diphosphoinositol polyphosphates and PtdIns(3,4,5)P3 for polyphosphoinositide-binding domains | Q37596231 |
| | Purified inositol hexakisphosphate kinase is an ATP synthase: diphosphoinositol pentakisphosphate as a high-energy phosphate donor | Q37635615 |
| | Receptor-dependent compartmentalization of PPIP5K1, a kinase with a cryptic polyphosphoinositide binding domain | Q37657049 |
| | Detecting UV-lesions in the genome: The modular CRL4 ubiquitin ligase does it best! | Q37873069 |
| | Protein phosphorylation from the perspective of systems biology. | Q37961317 |
| | Cell signalling by inositol pyrophosphates | Q37989043 |
| | Synthesis and biological actions of diphosphoinositol phosphates (inositol pyrophosphates), regulators of cell homeostasis | Q38040272 |
| | Inositol pyrophosphates: between signalling and metabolism | Q38110945 |
| | Metabolism and function of myo-inositol and inositol phospholipids | Q38164564 |
| | Akt/PKB activation and insulin signaling: a novel insulin signaling pathway in the treatment of type 2 diabetes | Q38194549 |
| | Molecular control of PtdIns(3,4,5)P3 signaling in neutrophils | Q38313393 |
| | IP6K1 Reduces Mesenchymal Stem/Stromal Cell Fitness and Potentiates High Fat Diet-Induced Skeletal Involution. | Q38430822 |
| | Global IP6K1 deletion enhances temperature modulated energy expenditure which reduces carbohydrate and fat induced weight gain | Q38433610 |
| | TNP [N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl)purine] ameliorates diet induced obesity and insulin resistance via inhibition of the IP6K1 pathway | Q38435784 |
| | Inositol hexakisphosphate kinase-1 interacts with perilipin1 to modulate lipolysis | Q38437282 |
| | Purine-based inhibitors of inositol-1,4,5-trisphosphate-3-kinase | Q38522112 |
| | Regulation of brown fat by AMP-activated protein kinase | Q38566113 |
| | Towards pharmacological intervention in inositol pyrophosphate signalling | Q38728101 |
| | Chemical tools for interrogating inositol pyrophosphate structure and function. | Q38837404 |
| | AKT in cancer: new molecular insights and advances in drug development | Q38846044 |
| | Unambiguous Identification of Serine and Threonine Pyrophosphorylation Using Neutral-Loss-Triggered Electron-Transfer/Higher-Energy Collision Dissociation. | Q38951747 |
| | Inositol phospholipids and cell surface receptor function | Q56091374 |
| | The detection, purification, structural characterization, and metabolism of diphosphoinositol pentakisphosphate(s) and bisdiphosphoinositol tetrakisphosphate(s) | Q70578917 |
| | Turnover of inositol polyphosphate pyrophosphates in pancreatoma cells | Q72952296 |
| | The diversity and possible functions of the inositol polyphosphate 5-phosphatases | Q77631387 |
| | Phosphate transfer from inositol pyrophosphates InsP5PP and InsP4(PP)2: a semi-empirical investigation | Q79256314 |
| | Crystal structure of inositol phosphate multikinase 2 and implications for substrate specificity | Q79271161 |
| | Extraction and analysis of soluble inositol polyphosphates from yeast | Q80093282 |
| | Asp1 from Schizosaccharomyces pombe binds a [2Fe-2S](2+) cluster which inhibits inositol pyrophosphate 1-phosphatase activity | Q36270671 |
| | Inositol pyrophosphates: metabolism and signaling | Q36375032 |
| | Low-grade serous carcinomas of the ovary contain very few point mutations | Q36415602 |
| | HSP90 regulates cell survival via inositol hexakisphosphate kinase-2. | Q36446083 |
| | IP6K2 is a client for HSP90 and a target for cancer therapeutics development | Q36446267 |
| | Gene deletion of inositol hexakisphosphate kinase 1 reveals inositol pyrophosphate regulation of insulin secretion, growth, and spermiogenesis | Q36497226 |
| | Inositol pyrophosphate synthesis by inositol hexakisphosphate kinase 1 is required for homologous recombination repair | Q36579532 |
| | Pleckstrin homology (PH) domains and phosphoinositides | Q36711258 |
| | Identification of a major IP5 kinase in Cryptococcus neoformans confirms that PP-IP5/IP7, not IP6, is essential for virulence | Q36754718 |
| | Regulation of UV-induced DNA damage response by ubiquitylation | Q36760894 |
| | Nudt3 is an mRNA decapping enzyme that modulates cell migration | Q36812733 |
| | Cigarette smoke (CS) and nicotine delay neutrophil spontaneous death via suppressing production of diphosphoinositol pentakisphosphate | Q36835730 |
| | Inositol pyrophosphates as mammalian cell signals | Q36886772 |
| | Inositol Hexakisphosphate Kinase 1 (IP6K1) Regulates Inositol Synthesis in Mammalian Cells | Q36898165 |
| | Inositol pyrophosphates mediate the DNA-PK/ATM-p53 cell death pathway by regulating CK2 phosphorylation of Tti1/Tel2 | Q33570316 |
| | The Obesity-Linked Gene Nudt3 Drosophila Homolog Aps Is Associated With Insulin Signaling | Q33631545 |
| | Role of synaptotagmin, a Ca2+ and inositol polyphosphate binding protein, in neurotransmitter release and neurite outgrowth | Q33652647 |
| | Inositol pyrophosphates mediate the effects of aging on bone marrow mesenchymal stem cells by inhibiting Akt signaling | Q33746634 |
| | Inositol pyrophosphates regulate cell death and telomere length through phosphoinositide 3-kinase-related protein kinases | Q33836143 |
| | Turnover of bis-diphosphoinositol tetrakisphosphate in a smooth muscle cell line is regulated by beta2-adrenergic receptors through a cAMP-mediated, A-kinase-independent mechanism | Q33888504 |
| | Zinc release from thapsigargin/IP3-sensitive stores in cultured cortical neurons | Q33964708 |
| | An adjacent pair of human NUDT genes on chromosome X are preferentially expressed in testis and encode two new isoforms of diphosphoinositol polyphosphate phosphohydrolase. | Q34137530 |
| | Release of Ca2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate | Q34264314 |
| | Cancer Inhibition by Inositol Hexaphosphate (IP6) and Inositol: From Laboratory to Clinic | Q34275641 |
| | Small molecule inhibitors of phospholipase C from a novel high-throughput screen. | Q34321407 |
| | Inositol hexakisphosphate kinase-2, a physiologic mediator of cell death | Q34366232 |
| | Phosphorylation of proteins by inositol pyrophosphates | Q34377316 |
| | Inositol pyrophosphates regulate endocytic trafficking | Q34392736 |
| | p53-mediated apoptosis requires inositol hexakisphosphate kinase-2 | Q34397020 |
| | The Nudix hydrolase superfamily | Q34479614 |
| | Identification of a functional nuclear translocation sequence in hPPIP5K2. | Q34481151 |
| | Inositol phospholipids and cell surface receptor function | Q34486299 |
| | Progressive but previously untreated CLL patients with greater array CGH complexity exhibit a less durable response to chemoimmunotherapy | Q34519192 |
| | Inositol hexakisphosphate kinase-1 mediates assembly/disassembly of the CRL4-signalosome complex to regulate DNA repair and cell death | Q34526364 |
| | How versatile are inositol phosphate kinases? | Q34542639 |
| | Casein kinase-2 mediates cell survival through phosphorylation and degradation of inositol hexakisphosphate kinase-2. | Q34573044 |
| | Protein pyrophosphorylation by inositol pyrophosphates is a posttranslational event | Q34688142 |
| | New concepts in chronic obstructive pulmonary disease | Q34930970 |
| | Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer | Q35034550 |
| | Understanding the relationship between DNA methylation and histone lysine methylation | Q35046027 |
| | Brown and beige fat in humans: thermogenic adipocytes that control energy and glucose homeostasis | Q35056776 |
| | Inositol pyrophosphates promote tumor growth and metastasis by antagonizing liver kinase B1 | Q35090038 |
| | Gene deletion of inositol hexakisphosphate kinase 2 predisposes to aerodigestive tract carcinoma | Q35208535 |
| | A novel method for the purification of inositol phosphates from biological samples reveals that no phytate is present in human plasma or urine | Q35318869 |
| | Fungal Inositol Pyrophosphate IP7 Is Crucial for Metabolic Adaptation to the Host Environment and Pathogenicity | Q35676308 |
| | Oncostatin M (OSM) protects against cardiac ischaemia/reperfusion injury in diabetic mice by regulating apoptosis, mitochondrial biogenesis and insulin sensitivity | Q35695541 |
| | Cellular delivery and photochemical release of a caged inositol-pyrophosphate induces PH-domain translocation in cellulo | Q35913992 |
| | Inositol Pyrophosphate Profiling of Two HCT116 Cell Lines Uncovers Variation in InsP8 Levels. | Q36176216 |
| | The significance of the 1-kinase/1-phosphatase activities of the PPIP5K family | Q38989731 |
| | Intimate connections: Inositol pyrophosphates at the interface of metabolic regulation and cell signaling. | Q39329205 |
| | An Investigation of Phytin | Q39480954 |
| | Characterization of a selective inhibitor of inositol hexakisphosphate kinases: use in defining biological roles and metabolic relationships of inositol pyrophosphates. | Q39885162 |
| | Requirement of inositol pyrophosphates for full exocytotic capacity in pancreatic beta cells | Q40046011 |
| | Signal transduction during environmental stress: InsP8 operates within highly restricted contexts | Q40413479 |
| | Apo2L/TRAIL induction and nuclear translocation of inositol hexakisphosphate kinase 2 during IFN-beta-induced apoptosis in ovarian carcinoma. | Q40474530 |
| | Genome-wide DNA methylation in saliva and body size of adolescent girls. | Q40495062 |
| | Protocols for regulation and study of diphosphoinositol polyphosphates. | Q40519725 |
| | Integrated genomic and proteomic analyses of gene expression in Mammalian cells | Q40538549 |
| | Ectopic expression of murine diphosphoinositol polyphosphate phosphohydrolase 1 attenuates signaling through the ERK1/2 pathway | Q40542484 |
| | Complex changes in cellular inositol phosphate complement accompany transit through the cell cycle | Q40583917 |
| | Inositol pyrophosphates are required for DNA hyperrecombination in protein kinase c1 mutant yeast | Q40750059 |
| | Dependence of energy metabolism on the density of cells in culture. | Q41024343 |
| | Establishing the stability and reversibility of protein pyrophosphorylation with synthetic peptides | Q41499357 |
| | Inositol pyrophosphates regulate cell growth and the environmental stress response by activating the HDAC Rpd3L. | Q41512865 |
| | The interconversion of inositol 1,3,4,5,6-pentakisphosphate and inositol tetrakisphosphates in AR4-2J cells | Q41594669 |
| | Adipocyte-specific deletion of Ip6k1 reduces diet-induced obesity by enhancing AMPK-mediated thermogenesis | Q41679412 |
| | myo-inositol pentakisphosphates. Structure, biological occurrence and phosphorylation to myo-inositol hexakisphosphate | Q41687573 |
| | The inositol phosphates in WRK1 rat mammary tumour cells | Q41810643 |
| | Inositol hexakisphosphate kinases induce cell death in Huntington disease | Q41820993 |
| | Inositol hexakisphosphate kinase 1 regulates neutrophil function in innate immunity by inhibiting phosphatidylinositol-(3,4,5)-trisphosphate signaling | Q41830941 |
| | Insulin signaling: inositol phosphates get into the Akt. | Q41841387 |
| | Inositol Hexakisphosphate Kinase-3 Regulates the Morphology and Synapse Formation of Cerebellar Purkinje Cells via Spectrin/Adducin. | Q41846418 |
| | Modulation of Epidermal Growth Factor Stimulated ERK Phosphorylation and Cell Motility by Inositol Trisphosphate Kinase. | Q41883939 |
| | Structures of diphospho-myo-inositol pentakisphosphate and bisdiphospho-myo-inositol tetrakisphosphate from Dictyostelium resolved by NMR analysis | Q41982271 |
| | Inositol pyrophosphates inhibit Akt signaling, thereby regulating insulin sensitivity and weight gain | Q42053859 |
| | Neuronal migration is mediated by inositol hexakisphosphate kinase 1 via α-actinin and focal adhesion kinase. | Q42318137 |
| | Inositol diphosphate signaling regulates telomere length | Q42641267 |
| | Turnover of inositol pentakisphosphates, inositol hexakisphosphate and diphosphoinositol polyphosphates in primary cultured hepatocytes | Q42745423 |
| | Rat brain inositol 1,4,5-trisphosphate 3-kinase. Ca2+-sensitivity, purification and antibody production | Q42794241 |
| | Regulation of a cyclin-CDK-CDK inhibitor complex by inositol pyrophosphates | Q42971039 |
| | Synthesis and characterization of non-hydrolysable diphosphoinositol polyphosphate second messengers. | Q43074238 |
| | Inositol pyrophosphates regulate RNA polymerase I-mediated rRNA transcription in Saccharomyces cerevisiae | Q43143870 |
| | The SIN1-PH Domain Connects mTORC2 to PI3K. | Q43183422 |
| | Inositol hexakisphosphate kinase-1 regulates behavioral responses via GSK3 signaling pathways | Q44273064 |
| | Inositol pyrophosphates mediate chemotaxis in Dictyostelium via pleckstrin homology domain-PtdIns(3,4,5)P3 interactions | Q44587829 |
| | Accumulation of [3H]-inositol into inositol polyphosphates during development of Dictyostelium | Q44610185 |
| | KO of 5-InsP7 kinase activity transforms the HCT116 colon cancer cell line into a hypermetabolic, growth-inhibited phenotype. | Q44876576 |
| | Signaling by higher inositol polyphosphates. Synthesis of bisdiphosphoinositol tetrakisphosphate ("InsP8") is selectively activated by hyperosmotic stress | Q45021750 |
| | Inositol hexakisphosphate kinase products contain diphosphate and triphosphate groups | Q45345663 |
| | Inositol pyrophosphates modulate hydrogen peroxide signalling. | Q45926680 |
| | Plc1p, Arg82p, and Kcs1p, enzymes involved in inositol pyrophosphate synthesis, are essential for phosphate regulation and polyphosphate accumulation in Saccharomyces cerevisiae | Q46468800 |
| | The regulation of membrane to cytosol partitioning of signalling proteins by phosphoinositides and their soluble headgroups | Q46771498 |
| | Inositol hexakisphosphate kinase 1 maintains hemostasis in mice by regulating platelet polyphosphate levels | Q46774343 |
| | Protein kinase- and lipase inhibitors of inositide metabolism deplete IP7 indirectly in pancreatic β-cells: Off-target effects on cellular bioenergetics and direct effects on IP6K activity | Q47637691 |
| | Development of a homogenous high-throughput assay for inositol hexakisphosphate kinase 1 activity | Q47944803 |
| | IP6K1 is essential for chromatoid body formation and temporal regulation of Tnp2 and Prm2 expression in mouse spermatids | Q48028376 |
| | Selective inhibition of inositol hexakisphosphate kinases (IP6Ks) enhances mesenchymal stem cell engraftment and improves therapeutic efficacy for myocardial infarction. | Q50456025 |
| | Inositol Hexakisphosphate Kinase 2 is a Presymptomatic Biomarker for Amyotrophic Lateral Sclerosis. | Q51055246 |
| | Contribution of polymorphic variation of inositol hexakisphosphate kinase 3 (IP6K3) gene promoter to the susceptibility to late onset Alzheimer's disease. | Q51282160 |
| | Influence of inositol pyrophosphates on cellular energy dynamics. | Q51847806 |
| | Inositol Hexakisphosphate Kinase 2 Promotes Cell Death in Cells with Cytoplasmic TDP-43 Aggregation. | Q52911856 |
| | NUDT3 rs206936 is associated with body mass index in obese Japanese women. | Q53108028 |
| | p53 Transgenic mice are highly susceptible to 4-nitroquinoline-1-oxide-induced oral cancer. | Q53617705 |
| | A Fluorescent Sensor and Gel Stain for Detection of Pyrophosphorylated Proteins. | Q53659145 |
| | Discovery of InsP6-kinases as InsP6-dephosphorylating enzymes provides a new mechanism of cytosolic InsP6 degradation driven by the cellular ATP/ADP ratio. | Q54349708 |
| | PPIP5K1 interacts with the exocyst complex through a C-terminal intrinsically disordered domain and regulates cell motility. | Q55031073 |
| P433 | issue | 2 | |
| P304 | page(s) | 1203-1227 | |
| P577 | publication date | 2017-12-27 | |
| P1433 | published in | Biological Reviews | Q2500948 |
| P1476 | title | The inositol pyrophosphate pathway in health and diseases | |
| P478 | volume | 93 | |